Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FWKKT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,627
Award facts
- Contract value 100% obligated
- $28,626.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $28,626.63 firm fixed price delivery order from the Defense Logistics Agency (DLA) on September 4, 2025, with completion targeted for September 5, 2025. The delivery order covers Cosentyx (secukinumab) 300 mg pens in 2 mL formulation, a prescription biologic medication used to treat autoimmune and inflammatory conditions. This award was competitively procured with no set-aside designation and represents a child contract under a larger indefinite delivery vehicle, reflecting DLA's established pharmaceutical procurement structure for military healthcare supply chains.
This award is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The prime indefinite delivery contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's demonstrated capability to fulfill federal medical procurement requirements across multiple therapeutic domains, combined with its established infrastructure for rapid delivery, positions it as a critical vendor within the DLA Medical Supply Chain supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FWKKT?
SPE2DB25FWKKT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FWKKT worth?
The government has obligated $28,627 on SPE2DB25FWKKT.
Is contract SPE2DB25FWKKT an order under another contract?
Yes. SPE2DB25FWKKT is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWKKT competed?
The extent of competition for SPE2DB25FWKKT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award